Chikungunya vaccine safety in pregnancy under review
Knowledge-focused
Not yet recruiting
This study looks at the safety of a chikungunya vaccine (VLA1553) given to pregnant women in Brazil. Researchers will track pregnancy and baby health outcomes for up to 12 weeks after birth in 200 vaccinated women and compare them to a similar group of pregnant women who received…
Sponsor: Valneva Austria GmbH • Aim: Knowledge-focused
Last updated May 17, 2026 15:09 UTC